3960 Aminoglycoside adenyltransferase AadA C-terminal domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 4 | 1.1 | 3.67× | not tested | |
| Organoheterocyclic compounds | 2 | 0.6 | 3.29× | not tested | |
| Organic oxygen compounds | 1 | 0.8 | 1.27× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.9 | 1.18× | not tested | |
| Homogeneous metal compounds | 1 | 1.9 | 0.52× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 10 |
| DB01082 | SRY | Streptomycin | 4 |
| DB00919 | SCM | Spectinomycin | 3 |
| DB11512 | 71R | Dihydrostreptomycin | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 10 |
| SRY | STREPTOMYCIN | 4 |
| SCM | SPECTINOMYCIN | 3 |
| 71R | dihydrostreptomycin | 2 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 2 |
| SMI | SPECTINOMYCIN | 2 |
| CL | CHLORIDE ION | 1 |
| MGmetal | MAGNESIUM ION | 1 |